Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun;61(6):1273-1276.
doi: 10.1007/s00125-018-4588-0. Epub 2018 Mar 6.

Defining outcomes for beta cell replacement therapy: a work in progress

Lorenzo Piemonti  1   2 , Eelco J P de Koning  3 , Thierry Berney  4 , Jon S Odorico  5 , James F Markmann  6 , Peter G Stock  7 , Michael R Rickels  8
Affiliations

Defining outcomes for beta cell replacement therapy: a work in progress

Lorenzo Piemonti et al. Diabetologia. 2018 Jun.

Abstract

Defined outcomes for beta cell replacement therapy in the treatment of diabetes are critically needed. Progress towards the clinical acceptance of pancreas and islet transplantation has been hampered by the lack of clear definitions of functional and efficacy outcomes, as well as a lack of consistently applied glycaemic control metrics, together with poor alignment with the field of artificial insulin delivery/artificial pancreas development. To address this problem, the International Pancreas & Islet Transplant Association (IPITA) collaborated with the European Pancreas and Islet Transplant Association (EPITA) to develop a consensus for a joint statement on the definition of function and failure of beta cell replacement therapies, which is summarised in this commentary.

Keywords: Islet transplantation; Outcomes; Pancreas transplantation.

PubMed Disclaimer

Conflict of interest statement

Duality of interest The authors declare that there is no duality of interest associated with this manuscript.

References

    1. Bartlett ST, Markmann JF, Johnson P et al. (2016) Report from IPITA-TTS opinion leaders meeting on the future of beta-cell replacement. Transplantation 100(Suppl 2):S1–44 - PMC - PubMed
    1. Harlan DM (2016) Islet transplantation for hypoglycemia unawareness/severe hypoglycemia: caveat emptor. Diabetes Care 39:1072–1074 - PubMed
    1. Rickels MR, Stock PG, de Koning EJP et al. (2018) Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop. Transpl Int 10.1111/tri.13138 - DOI - PMC - PubMed
    1. Rickels MR, Stock PG, de Koning EJP, et al. (2018) Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA Opinion Leaders Workshop. Transplantation: in press - PMC - PubMed
    1. Choudhary P, Rickels MR, Senior PA et al. (2015) Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care 38:1016–1029 - PMC - PubMed

Publication types

LinkOut - more resources